These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 8237479

  • 41. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
    Brüel A, Vegger JB, Raffalt AC, Andersen JE, Thomsen JS.
    Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
    [Abstract] [Full Text] [Related]

  • 42. Impacts of the N-terminal fragment analog of human parathyroid hormone on structure, composition and biomechanics of bone.
    Chunxiao W, Yu Z, Wentao L, Jingjing L, Jiahui Y, Qingmei C.
    Eur J Pharm Sci; 2012 Dec 18; 47(5):926-33. PubMed ID: 23046835
    [Abstract] [Full Text] [Related]

  • 43. Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats.
    Ejersted C, Andreassen TT, Nilsson MH, Oxlund H.
    Eur J Endocrinol; 1994 Feb 18; 130(2):201-7. PubMed ID: 8130897
    [Abstract] [Full Text] [Related]

  • 44. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
    Rowshan HH, Parham MA, Baur DA, McEntee RD, Cauley E, Carriere DT, Wood JC, Demsar WJ, Pizarro JM.
    J Oral Maxillofac Surg; 2010 Feb 18; 68(2):260-7. PubMed ID: 20116693
    [Abstract] [Full Text] [Related]

  • 45. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties.
    Lotinun S, Evans GL, Bronk JT, Bolander ME, Wronski TJ, Ritman EL, Turner RT.
    J Bone Miner Res; 2004 Jul 18; 19(7):1165-71. PubMed ID: 15177000
    [Abstract] [Full Text] [Related]

  • 46. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.
    Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, Seki A, Sun YX, Yamamoto T.
    Bone; 2007 Jun 18; 40(6):1475-82. PubMed ID: 17369013
    [Abstract] [Full Text] [Related]

  • 47. Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats.
    Toromanoff A, Ammann P, Riond JL.
    Bone; 1998 Mar 18; 22(3):217-23. PubMed ID: 9514214
    [Abstract] [Full Text] [Related]

  • 48. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.
    Sato M, Vahle J, Schmidt A, Westmore M, Smith S, Rowley E, Ma LY.
    Endocrinology; 2002 Sep 18; 143(9):3230-42. PubMed ID: 12193534
    [Abstract] [Full Text] [Related]

  • 49. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.
    Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschman T, Coffin JD.
    Biochem Biophys Res Commun; 2006 Mar 24; 341(4):989-94. PubMed ID: 16455048
    [Abstract] [Full Text] [Related]

  • 50. The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: an analysis of pit size and the resorption focus.
    Murrills RJ, Stein LS, Fey CP, Dempster DW.
    Endocrinology; 1990 Dec 24; 127(6):2648-53. PubMed ID: 2249618
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats.
    Moriyama I, Iwamoto J, Takeda T, Toyama Y.
    J Orthop Sci; 2002 Dec 24; 7(3):379-85. PubMed ID: 12077665
    [Abstract] [Full Text] [Related]

  • 53. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats.
    Gera I, Hock JM, Gunness-Hey M, Fonseca J, Raisz LG.
    Calcif Tissue Int; 1987 Apr 24; 40(4):206-11. PubMed ID: 3107773
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus.
    Hamann C, Picke AK, Campbell GM, Balyura M, Rauner M, Bernhardt R, Huber G, Morlock MM, Günther KP, Bornstein SR, Glüer CC, Ludwig B, Hofbauer LC.
    Endocrinology; 2014 Apr 24; 155(4):1197-206. PubMed ID: 24467747
    [Abstract] [Full Text] [Related]

  • 56. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.
    Gunness-Hey M, Hock JM.
    Metab Bone Dis Relat Res; 1984 Apr 24; 5(4):177-81. PubMed ID: 6738355
    [Abstract] [Full Text] [Related]

  • 57. In vivo parathyroid hormone treatments and RNA isolation and analysis.
    Li X, Qin L, Partridge NC.
    Methods Mol Biol; 2008 Apr 24; 455():79-87. PubMed ID: 18463811
    [Abstract] [Full Text] [Related]

  • 58. Parathyroid hormone and its effects on dental tissues.
    Aggarwal P, Zavras A.
    Oral Dis; 2012 Jan 24; 18(1):48-54. PubMed ID: 21895887
    [Abstract] [Full Text] [Related]

  • 59. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats.
    Ejersted C, Andreassen TT, Hauge EM, Melsen F, Oxlund H.
    Bone; 1995 Dec 24; 17(6):507-11. PubMed ID: 8835302
    [Abstract] [Full Text] [Related]

  • 60. Interrelationships between densitometric, geometric, and mechanical properties of rat femora: inferences concerning mechanical regulation of bone modeling.
    Ferretti JL, Capozza RF, Mondelo N, Zanchetta JR.
    J Bone Miner Res; 1993 Nov 24; 8(11):1389-96. PubMed ID: 8266830
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.